- United States
- /
- Software
- /
- NYSE:PATH
UiPath (PATH) Stock Could Be 24% Undervalued After Maestro Case Launch
UiPath (PATH) is back in focus after launching Maestro Case, an AI-native case management capability that targets complex, exception-heavy workflows, with early adopters reporting sizable efficiency gains and projected cost savings.
See our latest analysis for UiPath.
Despite Maestro Case and recent customer wins such as One New Zealand Limited, short term selling pressure has left UiPath’s share price down 33.75% year to date and the 5 year total shareholder return down 84.94%. This points to fading long term momentum even as the 30 day share price return of 2.43% hints at pockets of renewed interest around AI automation catalysts.
If Maestro Case has you thinking more broadly about automation opportunities, this is a useful moment to scan other robotics and automation stocks using the Simply Wall St screener for 32 robotics and automation stocks
With UiPath stock down sharply over multi year periods, but trading at a discount to some fair value estimates and analyst targets, the key question is whether weakness has gone too far or if the market already reflects its AI automation potential.
Most Popular Narrative: 24% Undervalued
On the current numbers, the most followed UiPath narrative points to a fair value of $13.81, compared with the latest close of $10.52. This frames the stock as materially discounted by that framework.
UiPath's focus on accelerating innovation across the agentic automation road map is expected to grow deeper customer relationships and strategic partnerships, likely driving future revenue growth. Increased adoption of UiPath's platform among existing customers, supported by strategic changes in the go-to-market structure, is aimed at enhancing customer engagement and boosting ARR growth.
Curious what underpins that $13.81 fair value for UiPath stock? The narrative leans on specific revenue growth paths, margin compression, and a future earnings multiple that may surprise many readers.
Result: Fair Value of $13.81 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, UiPath stock still faces meaningful risks, including deal delays tied to geopolitics and customer budget caution, as well as SaaS transition and FX pressures on reported growth.
Find out about the key risks to this UiPath narrative.
Next Steps
With mixed sentiment around UiPath and its AI automation potential, this is a good time to review the underlying data yourself, weigh the risks against the upside, and see how the balance of 4 key rewards aligns with your own view.
Looking for more investment ideas beyond UiPath?
If you only stop at UiPath, you may miss other stocks that fit your goals, so keep your options open and keep building your watchlist.
- Target dependable income by reviewing companies screened for payout strength using the 9 dividend fortresses
- Spot quality at a potential discount by scanning the 44 high quality undervalued stocks that combine fundamentals with pricing that may appeal to value focused investors.
- Prioritise resilience by checking stocks highlighted for lower risk profiles through the 67 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:PATH
UiPath
Provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.
Very undervalued with flawless balance sheet.
Similar Companies
Market Insights
Weekly Picks

This small biotech is developing technology that could potentially change how tissue is rebuilt

The Picks-and-Shovels Leader of the Grid Supercycle
KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Invinity Energy Systems: All About That BESS
Recently Updated Narratives

Strong in favor of diversity in value portfolio
Relatively mispriced taken into account its intrinsic growth profile, providing a defensive, cash-generative entry point for investors
Nova Ljubljanska Banka d.d. future looks bright with a profit margin change of 38%
Popular Narratives

Investment Analysis (May 2026)

Adobe: A Probabilistic Case for Undervaluation

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
